HRTS Holdings Information

HRTS is an equity ETF with a total of 46 individual holdings. The top holdings are Eli Lilly and Company stock at 12.11%, UnitedHealth Group at 5.60%, Novo Nordisk at 5.02%, Roche Holding AG at 4.41%, and Merck & Co. at 4.35%.

Total Holdings

Top 10 Percentage

49.69%

Asset Class

Equity

ETF Category

Health

Assets

52.14M

PE Ratio

20.35

Breakdown by Country

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	12.11%	5,448
2	UNH	UnitedHealth Group Incorporated	5.60%	7,206
3	CPH: NOVO.B	Novo Nordisk A/S	5.02%	59,848
4	RHHBY	Roche Holding AG	4.41%	44,832
5	MRK	Merck & Co., Inc.	4.35%	18,795
6	LON: AZN	AstraZeneca PLC	3.93%	11,252
7	TMO	Thermo Fisher Scientific Inc.	3.84%	4,212
8	JNJ	Johnson & Johnson	3.80%	8,328
9	SWX: NOVN	Novartis AG	3.43%	11,704
10	GILD	Gilead Sciences, Inc.	3.22%	13,348
11	RVMD	Revolution Medicines, Inc.	3.16%	11,043
12	VRTX	Vertex Pharmaceuticals Incorporated	2.91%	3,420
13	ABT	Abbott Laboratories	2.73%	15,913
14	BBIO	BridgeBio Pharma, Inc.	2.65%	20,461
15	DHR	Danaher Corporation	2.63%	7,607
16	ABBV	AbbVie Inc.	2.48%	5,751
17	CYTK	Cytokinetics, Incorporated	2.28%	17,182
18	BMY	Bristol-Myers Squibb Company	2.08%	19,064
19	MDT	Medtronic plc	2.04%	13,290
20	TEVA	Teva Pharmaceutical Industries Limited	2.02%	30,473
21	AMGN	Amgen Inc.	2.01%	2,965
22	DXCM	DexCom, Inc.	1.96%	13,601
23	MCK	McKesson Corporation	1.81%	1,203
24	EW	Edwards Lifesciences Corporation	1.73%	10,557
25	REGN	Regeneron Pharmaceuticals, Inc.	1.66%	1,417

Showing 25 of 46 holdings

Subscribe to see the full list

Activate Now

As of Jun 11, 2026